SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program

The capacity for tumor cells to metastasize efficiently is directly linked to their ability to colonize secondary sites. Here we identify Six2, a developmental transcription factor, as a critical regulator of a breast cancer stem cell program that enables metastatic colonization. In several triple-n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2019-02, Vol.79 (4), p.720-734
Hauptverfasser: Oliphant, Michael U J, Vincent, Melanie Y, Galbraith, Matthew D, Pandey, Ahwan, Zaberezhnyy, Vadym, Rudra, Pratyaydipta, Johnson, Katherine R, Costello, James C, Ghosh, Debashis, DeGregori, James, Espinosa, Joaquin M, Ford, Heide L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 734
container_issue 4
container_start_page 720
container_title Cancer research (Chicago, Ill.)
container_volume 79
creator Oliphant, Michael U J
Vincent, Melanie Y
Galbraith, Matthew D
Pandey, Ahwan
Zaberezhnyy, Vadym
Rudra, Pratyaydipta
Johnson, Katherine R
Costello, James C
Ghosh, Debashis
DeGregori, James
Espinosa, Joaquin M
Ford, Heide L
description The capacity for tumor cells to metastasize efficiently is directly linked to their ability to colonize secondary sites. Here we identify Six2, a developmental transcription factor, as a critical regulator of a breast cancer stem cell program that enables metastatic colonization. In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Srr2 enhancer, promoting expression and downstream expression of , which are both key pluripotency factors. Regulation of by Six2 enhanced cancer stem cell properties and increased metastatic colonization. and expression correlated highly in breast cancers including TNBC, where a Six2 expression signature was predictive of metastatic burden and poor clinical outcome. Our findings demonstrate that a SIX2/SOX2 axis is required for efficient metastatic colonization, underscoring a key role for stemness factors in outgrowth at secondary sites. SIGNIFICANCE: These findings provide novel mechanistic insight into stemness and the metastatic outgrowth of triple-negative breast cancer cells. http://cancerres.aacrjournals.org/content/canres/79/4/720/F1.large.jpg.
doi_str_mv 10.1158/0008-5472.CAN-18-1791
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6586234</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2164101422</sourcerecordid><originalsourceid>FETCH-LOGICAL-c463t-56a88dcd88deb12ffeb7542f1a846171a5415af036881c7309052d8de55bd5493</originalsourceid><addsrcrecordid>eNpVkV9LHDEUxYNYdKt-BEsefRnNzSSZ7Isgo9aFbS1dC30LdzOZbWT-aJIR-u3Noi4thBvuzTknCT9CToGdA0h9wRjThRQVP6-vvhegC6jmsEdmIEtdVELIfTLbaQ7J5xgfcyuByQNyWDLFVMXZjPSrxW9Ov7nGY3KRLnMtVgk3Ls8Sxrx8pC8e6bUPzib6022mDpMfBzq2dHWfzTg0dDE0k_2YIq1xsC7QVXI9rV3X0R9h3ATsj8mnFrvoTt73I_Lr9uahviuW918X9dWysEKVqZAKtW5sk4tbA29bt66k4C2gFgoqQClAYstKpTXYqmRzJnmTxVKuGynm5RG5fMt9mta9a6wbUsDOPAXfY_hrRvTm_5PB_zGb8cUoqRUvRQ44ew8I4_PkYjK9jzb_BAc3TtFwUAIYCM6zVL5JbRhjDK7dXQPMbFGZLQazxWAyKgPabFFl35d_37hzfbApXwH7hY8a</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2164101422</pqid></control><display><type>article</type><title>SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Oliphant, Michael U J ; Vincent, Melanie Y ; Galbraith, Matthew D ; Pandey, Ahwan ; Zaberezhnyy, Vadym ; Rudra, Pratyaydipta ; Johnson, Katherine R ; Costello, James C ; Ghosh, Debashis ; DeGregori, James ; Espinosa, Joaquin M ; Ford, Heide L</creator><creatorcontrib>Oliphant, Michael U J ; Vincent, Melanie Y ; Galbraith, Matthew D ; Pandey, Ahwan ; Zaberezhnyy, Vadym ; Rudra, Pratyaydipta ; Johnson, Katherine R ; Costello, James C ; Ghosh, Debashis ; DeGregori, James ; Espinosa, Joaquin M ; Ford, Heide L</creatorcontrib><description>The capacity for tumor cells to metastasize efficiently is directly linked to their ability to colonize secondary sites. Here we identify Six2, a developmental transcription factor, as a critical regulator of a breast cancer stem cell program that enables metastatic colonization. In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Srr2 enhancer, promoting expression and downstream expression of , which are both key pluripotency factors. Regulation of by Six2 enhanced cancer stem cell properties and increased metastatic colonization. and expression correlated highly in breast cancers including TNBC, where a Six2 expression signature was predictive of metastatic burden and poor clinical outcome. Our findings demonstrate that a SIX2/SOX2 axis is required for efficient metastatic colonization, underscoring a key role for stemness factors in outgrowth at secondary sites. SIGNIFICANCE: These findings provide novel mechanistic insight into stemness and the metastatic outgrowth of triple-negative breast cancer cells. http://cancerres.aacrjournals.org/content/canres/79/4/720/F1.large.jpg.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-18-1791</identifier><identifier>PMID: 30606720</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Apoptosis ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Cell Proliferation ; Female ; Follow-Up Studies ; Gene Expression Regulation, Neoplastic ; Homeodomain Proteins - genetics ; Homeodomain Proteins - metabolism ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Inbred NOD ; Mice, SCID ; Nanog Homeobox Protein - genetics ; Nanog Homeobox Protein - metabolism ; Neoplasm Metastasis ; Neoplasm Recurrence, Local - genetics ; Neoplasm Recurrence, Local - metabolism ; Neoplasm Recurrence, Local - pathology ; Neoplastic Stem Cells - metabolism ; Neoplastic Stem Cells - pathology ; Nerve Tissue Proteins - genetics ; Nerve Tissue Proteins - metabolism ; Prognosis ; SOXB1 Transcription Factors - genetics ; SOXB1 Transcription Factors - metabolism ; Survival Rate ; Triple Negative Breast Neoplasms - genetics ; Triple Negative Breast Neoplasms - metabolism ; Triple Negative Breast Neoplasms - secondary ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays</subject><ispartof>Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4), p.720-734</ispartof><rights>2019 American Association for Cancer Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c463t-56a88dcd88deb12ffeb7542f1a846171a5415af036881c7309052d8de55bd5493</citedby><cites>FETCH-LOGICAL-c463t-56a88dcd88deb12ffeb7542f1a846171a5415af036881c7309052d8de55bd5493</cites><orcidid>0000-0003-3158-9682 ; 0000-0002-1089-7283 ; 0000-0003-0485-3927</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,3343,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30606720$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oliphant, Michael U J</creatorcontrib><creatorcontrib>Vincent, Melanie Y</creatorcontrib><creatorcontrib>Galbraith, Matthew D</creatorcontrib><creatorcontrib>Pandey, Ahwan</creatorcontrib><creatorcontrib>Zaberezhnyy, Vadym</creatorcontrib><creatorcontrib>Rudra, Pratyaydipta</creatorcontrib><creatorcontrib>Johnson, Katherine R</creatorcontrib><creatorcontrib>Costello, James C</creatorcontrib><creatorcontrib>Ghosh, Debashis</creatorcontrib><creatorcontrib>DeGregori, James</creatorcontrib><creatorcontrib>Espinosa, Joaquin M</creatorcontrib><creatorcontrib>Ford, Heide L</creatorcontrib><title>SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>The capacity for tumor cells to metastasize efficiently is directly linked to their ability to colonize secondary sites. Here we identify Six2, a developmental transcription factor, as a critical regulator of a breast cancer stem cell program that enables metastatic colonization. In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Srr2 enhancer, promoting expression and downstream expression of , which are both key pluripotency factors. Regulation of by Six2 enhanced cancer stem cell properties and increased metastatic colonization. and expression correlated highly in breast cancers including TNBC, where a Six2 expression signature was predictive of metastatic burden and poor clinical outcome. Our findings demonstrate that a SIX2/SOX2 axis is required for efficient metastatic colonization, underscoring a key role for stemness factors in outgrowth at secondary sites. SIGNIFICANCE: These findings provide novel mechanistic insight into stemness and the metastatic outgrowth of triple-negative breast cancer cells. http://cancerres.aacrjournals.org/content/canres/79/4/720/F1.large.jpg.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Cell Proliferation</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Homeodomain Proteins - genetics</subject><subject>Homeodomain Proteins - metabolism</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred NOD</subject><subject>Mice, SCID</subject><subject>Nanog Homeobox Protein - genetics</subject><subject>Nanog Homeobox Protein - metabolism</subject><subject>Neoplasm Metastasis</subject><subject>Neoplasm Recurrence, Local - genetics</subject><subject>Neoplasm Recurrence, Local - metabolism</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplastic Stem Cells - metabolism</subject><subject>Neoplastic Stem Cells - pathology</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Prognosis</subject><subject>SOXB1 Transcription Factors - genetics</subject><subject>SOXB1 Transcription Factors - metabolism</subject><subject>Survival Rate</subject><subject>Triple Negative Breast Neoplasms - genetics</subject><subject>Triple Negative Breast Neoplasms - metabolism</subject><subject>Triple Negative Breast Neoplasms - secondary</subject><subject>Tumor Cells, Cultured</subject><subject>Xenograft Model Antitumor Assays</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkV9LHDEUxYNYdKt-BEsefRnNzSSZ7Isgo9aFbS1dC30LdzOZbWT-aJIR-u3Noi4thBvuzTknCT9CToGdA0h9wRjThRQVP6-vvhegC6jmsEdmIEtdVELIfTLbaQ7J5xgfcyuByQNyWDLFVMXZjPSrxW9Ov7nGY3KRLnMtVgk3Ls8Sxrx8pC8e6bUPzib6022mDpMfBzq2dHWfzTg0dDE0k_2YIq1xsC7QVXI9rV3X0R9h3ATsj8mnFrvoTt73I_Lr9uahviuW918X9dWysEKVqZAKtW5sk4tbA29bt66k4C2gFgoqQClAYstKpTXYqmRzJnmTxVKuGynm5RG5fMt9mta9a6wbUsDOPAXfY_hrRvTm_5PB_zGb8cUoqRUvRQ44ew8I4_PkYjK9jzb_BAc3TtFwUAIYCM6zVL5JbRhjDK7dXQPMbFGZLQazxWAyKgPabFFl35d_37hzfbApXwH7hY8a</recordid><startdate>20190215</startdate><enddate>20190215</enddate><creator>Oliphant, Michael U J</creator><creator>Vincent, Melanie Y</creator><creator>Galbraith, Matthew D</creator><creator>Pandey, Ahwan</creator><creator>Zaberezhnyy, Vadym</creator><creator>Rudra, Pratyaydipta</creator><creator>Johnson, Katherine R</creator><creator>Costello, James C</creator><creator>Ghosh, Debashis</creator><creator>DeGregori, James</creator><creator>Espinosa, Joaquin M</creator><creator>Ford, Heide L</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3158-9682</orcidid><orcidid>https://orcid.org/0000-0002-1089-7283</orcidid><orcidid>https://orcid.org/0000-0003-0485-3927</orcidid></search><sort><creationdate>20190215</creationdate><title>SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program</title><author>Oliphant, Michael U J ; Vincent, Melanie Y ; Galbraith, Matthew D ; Pandey, Ahwan ; Zaberezhnyy, Vadym ; Rudra, Pratyaydipta ; Johnson, Katherine R ; Costello, James C ; Ghosh, Debashis ; DeGregori, James ; Espinosa, Joaquin M ; Ford, Heide L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c463t-56a88dcd88deb12ffeb7542f1a846171a5415af036881c7309052d8de55bd5493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Cell Proliferation</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Homeodomain Proteins - genetics</topic><topic>Homeodomain Proteins - metabolism</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred NOD</topic><topic>Mice, SCID</topic><topic>Nanog Homeobox Protein - genetics</topic><topic>Nanog Homeobox Protein - metabolism</topic><topic>Neoplasm Metastasis</topic><topic>Neoplasm Recurrence, Local - genetics</topic><topic>Neoplasm Recurrence, Local - metabolism</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplastic Stem Cells - metabolism</topic><topic>Neoplastic Stem Cells - pathology</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Prognosis</topic><topic>SOXB1 Transcription Factors - genetics</topic><topic>SOXB1 Transcription Factors - metabolism</topic><topic>Survival Rate</topic><topic>Triple Negative Breast Neoplasms - genetics</topic><topic>Triple Negative Breast Neoplasms - metabolism</topic><topic>Triple Negative Breast Neoplasms - secondary</topic><topic>Tumor Cells, Cultured</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oliphant, Michael U J</creatorcontrib><creatorcontrib>Vincent, Melanie Y</creatorcontrib><creatorcontrib>Galbraith, Matthew D</creatorcontrib><creatorcontrib>Pandey, Ahwan</creatorcontrib><creatorcontrib>Zaberezhnyy, Vadym</creatorcontrib><creatorcontrib>Rudra, Pratyaydipta</creatorcontrib><creatorcontrib>Johnson, Katherine R</creatorcontrib><creatorcontrib>Costello, James C</creatorcontrib><creatorcontrib>Ghosh, Debashis</creatorcontrib><creatorcontrib>DeGregori, James</creatorcontrib><creatorcontrib>Espinosa, Joaquin M</creatorcontrib><creatorcontrib>Ford, Heide L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oliphant, Michael U J</au><au>Vincent, Melanie Y</au><au>Galbraith, Matthew D</au><au>Pandey, Ahwan</au><au>Zaberezhnyy, Vadym</au><au>Rudra, Pratyaydipta</au><au>Johnson, Katherine R</au><au>Costello, James C</au><au>Ghosh, Debashis</au><au>DeGregori, James</au><au>Espinosa, Joaquin M</au><au>Ford, Heide L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2019-02-15</date><risdate>2019</risdate><volume>79</volume><issue>4</issue><spage>720</spage><epage>734</epage><pages>720-734</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><abstract>The capacity for tumor cells to metastasize efficiently is directly linked to their ability to colonize secondary sites. Here we identify Six2, a developmental transcription factor, as a critical regulator of a breast cancer stem cell program that enables metastatic colonization. In several triple-negative breast cancer (TNBC) models, Six2 enhanced the expression of genes associated with embryonic stem cell programs. Six2 directly bound the Srr2 enhancer, promoting expression and downstream expression of , which are both key pluripotency factors. Regulation of by Six2 enhanced cancer stem cell properties and increased metastatic colonization. and expression correlated highly in breast cancers including TNBC, where a Six2 expression signature was predictive of metastatic burden and poor clinical outcome. Our findings demonstrate that a SIX2/SOX2 axis is required for efficient metastatic colonization, underscoring a key role for stemness factors in outgrowth at secondary sites. SIGNIFICANCE: These findings provide novel mechanistic insight into stemness and the metastatic outgrowth of triple-negative breast cancer cells. http://cancerres.aacrjournals.org/content/canres/79/4/720/F1.large.jpg.</abstract><cop>United States</cop><pmid>30606720</pmid><doi>10.1158/0008-5472.CAN-18-1791</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-3158-9682</orcidid><orcidid>https://orcid.org/0000-0002-1089-7283</orcidid><orcidid>https://orcid.org/0000-0003-0485-3927</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4), p.720-734
issn 0008-5472
1538-7445
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6586234
source MEDLINE; American Association for Cancer Research; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Apoptosis
Biomarkers, Tumor - genetics
Biomarkers, Tumor - metabolism
Cell Proliferation
Female
Follow-Up Studies
Gene Expression Regulation, Neoplastic
Homeodomain Proteins - genetics
Homeodomain Proteins - metabolism
Humans
Mice
Mice, Inbred BALB C
Mice, Inbred NOD
Mice, SCID
Nanog Homeobox Protein - genetics
Nanog Homeobox Protein - metabolism
Neoplasm Metastasis
Neoplasm Recurrence, Local - genetics
Neoplasm Recurrence, Local - metabolism
Neoplasm Recurrence, Local - pathology
Neoplastic Stem Cells - metabolism
Neoplastic Stem Cells - pathology
Nerve Tissue Proteins - genetics
Nerve Tissue Proteins - metabolism
Prognosis
SOXB1 Transcription Factors - genetics
SOXB1 Transcription Factors - metabolism
Survival Rate
Triple Negative Breast Neoplasms - genetics
Triple Negative Breast Neoplasms - metabolism
Triple Negative Breast Neoplasms - secondary
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
title SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T14%3A42%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SIX2%20Mediates%20Late-Stage%20Metastasis%20via%20Direct%20Regulation%20of%20SOX2%20and%20Induction%20of%20a%20Cancer%20Stem%20Cell%20Program&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=Oliphant,%20Michael%20U%20J&rft.date=2019-02-15&rft.volume=79&rft.issue=4&rft.spage=720&rft.epage=734&rft.pages=720-734&rft.issn=0008-5472&rft.eissn=1538-7445&rft_id=info:doi/10.1158/0008-5472.CAN-18-1791&rft_dat=%3Cproquest_pubme%3E2164101422%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2164101422&rft_id=info:pmid/30606720&rfr_iscdi=true